To main content To main navigation

Lara Barazzuol

Principal Investigator, Group leader of Cancer treatment-induced neurocognitive dysfunction Profile

Principal Investigator, Group leader of Cancer treatment-induced neurocognitive dysfunction

Contact information

Discover our research

Effects of the adenosine A2A receptor antagonist KW6002 on the dopaminergic system, motor performance, and neuroinflammation in a rat model of Parkinson's disease.

2024, Neuropharmacology

Proton therapy induces a local microglial neuroimmune response

2024, Radiotherapy and Oncology

All publications

Roles

- Mechanisms of cancer treatment-induced neurocognitive declineLara Barazzuol (Speaker) 15-Dec-2022 Academic presentation > Academic
- Mechanisms of cancer treatment-induced neurocognitive declineLara Barazzuol (Speaker) 19-Oct-2022 Academic presentation > Academic
- Brain organoids as models to study radiation-induced neurotoxicityLara Barazzuol (Speaker) 6-May-2022 Academic presentation > Academic
- ESTRO 2022 (Event)Lara Barazzuol (Member) 6-May-2022 → 10-May-2022 Membership > Academic
- IMPACT: image guided particle irradations for preclinical researchSytze Brandenburg (Speaker), Lara Barazzuol (Contributor), Stefan Both (Contributor), Rob Coppes (Contributor), Marc Jan van Goethem (Contributor), Brian Jones (Contributor), Peter van Luijk (Contributor), Justin Malimban (Contributor) 22-Mar-2022 Academic presentation > Academic
All activities
- Adrian C. Begg AwardLara Barazzuol, 2017 Academic
- Bas Mulder AwardLara Barazzuol, 2017 Academic
- European Radiation Research Society Best Poster AwardLara Barazzuol, 2016 Academic
- British Institute of Radiology Nic McNally AwardLara Barazzuol, 2015 Academic
- International Congress of Radiation Research 2015 Young Investigator AwardLara Barazzuol, 2015 Academic
All prizes

Contact